Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Institutions: University of California, San Francisco, University of Turin, Ruhrlandklinik, University of Duisburg-Essen, Vanderbilt University Medical Center, Duke University, Medical University of South Carolina, Universitair Ziekenhuis Leuven, Assistance Publique – Hôpitaux de Paris, Hôpital Avicenne, National Jewish Health
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: idiopathic pulmonary fibrosis, interferon gamma-1b, survival, mortality, treatment efficacy, adverse events, influenza-like illness, medication adherence, lung function, diffusing capacity for carbon monoxide, forced vital capacity, subcutaneous interferon therapy, INSPIRE trial, subgroup analysis bias, treatment effect heterogeneity
Open Access status: green
OpenAlex ID: W2131029325
